Red  ||| S:0 E:4 ||| JJ
blood  ||| S:4 E:10 ||| NN
cell  ||| S:10 E:15 ||| NN
transfusion  ||| S:15 E:27 ||| NN
is  ||| S:27 E:30 ||| VBZ
associated  ||| S:30 E:41 ||| VBN
with  ||| S:41 E:46 ||| IN
further  ||| S:46 E:54 ||| JJ
bleeding  ||| S:54 E:63 ||| NN
and  ||| S:63 E:67 ||| CC
fresh-frozen  ||| S:67 E:80 ||| JJ
plasma  ||| S:80 E:87 ||| NN
with  ||| S:87 E:92 ||| IN
mortality  ||| S:92 E:102 ||| NN
in  ||| S:102 E:105 ||| IN
nonvariceal  ||| S:105 E:117 ||| JJ
upper  ||| S:117 E:123 ||| JJ
gastrointestinal  ||| S:123 E:140 ||| NNS
bleeding  ||| S:140 E:149 ||| VBG
Blood  ||| S:149 E:155 ||| JJ
products  ||| S:155 E:164 ||| NNS
are  ||| S:164 E:168 ||| VBP
commonly  ||| S:168 E:177 ||| RB
transfused  ||| S:177 E:188 ||| VBN
for  ||| S:188 E:192 ||| IN
patients  ||| S:192 E:201 ||| NNS
with  ||| S:201 E:206 ||| IN
nonvariceal  ||| S:206 E:218 ||| FW
upper  ||| S:218 E:224 ||| FW
gastrointestinal  ||| S:224 E:241 ||| FW
bleeding  ||| S:241 E:250 ||| FW
( ||| S:250 E:251 ||| -LRB-
NVUGIB ||| S:251 E:257 ||| NNP
) ||| S:257 E:258 ||| -RRB-
.  ||| S:258 E:260 ||| .
While  ||| S:260 E:266 ||| IN
concerns  ||| S:266 E:275 ||| NNS
exist  ||| S:275 E:281 ||| VBP
about  ||| S:281 E:287 ||| RB
further  ||| S:287 E:295 ||| JJ
bleeding  ||| S:295 E:304 ||| NN
and  ||| S:304 E:308 ||| CC
mortality  ||| S:308 E:318 ||| NN
in  ||| S:318 E:321 ||| IN
subsets  ||| S:321 E:329 ||| NN
of  ||| S:329 E:332 ||| IN
patients  ||| S:332 E:341 ||| NNS
receiving  ||| S:341 E:351 ||| VBG
red  ||| S:351 E:355 ||| JJ
blood  ||| S:355 E:361 ||| NN
cell  ||| S:361 E:366 ||| NN
( ||| S:366 E:367 ||| -LRB-
RBC ||| S:367 E:370 ||| NNP
)  ||| S:370 E:372 ||| -RRB-
transfusion ||| S:372 E:383 ||| NN
,  ||| S:383 E:385 ||| ,
the  ||| S:385 E:389 ||| DT
impact  ||| S:389 E:396 ||| NN
of  ||| S:396 E:399 ||| IN
non-RBC  ||| S:399 E:407 ||| JJ
blood  ||| S:407 E:413 ||| NN
products  ||| S:413 E:422 ||| NNS
has  ||| S:422 E:426 ||| VBZ
not  ||| S:426 E:430 ||| RB
previously  ||| S:430 E:441 ||| RB
been  ||| S:441 E:446 ||| VBN
systematically  ||| S:446 E:461 ||| RB
investigated ||| S:461 E:473 ||| VBN
.  ||| S:473 E:475 ||| .
The  ||| S:475 E:479 ||| DT
aim  ||| S:479 E:483 ||| NN
of  ||| S:483 E:486 ||| IN
the  ||| S:486 E:490 ||| DT
study  ||| S:490 E:496 ||| NN
was  ||| S:496 E:500 ||| VBD
to  ||| S:500 E:503 ||| TO
investigate  ||| S:503 E:515 ||| VB
the  ||| S:515 E:519 ||| DT
associations  ||| S:519 E:532 ||| NNS
between  ||| S:532 E:540 ||| IN
blood  ||| S:540 E:546 ||| NN
products  ||| S:546 E:555 ||| NNS
transfusion ||| S:555 E:566 ||| NN
,  ||| S:566 E:568 ||| ,
further  ||| S:568 E:576 ||| JJ
bleeding ||| S:576 E:584 ||| NN
,  ||| S:584 E:586 ||| ,
and  ||| S:586 E:590 ||| CC
mortality  ||| S:590 E:600 ||| NN
after  ||| S:600 E:606 ||| IN
acute  ||| S:606 E:612 ||| JJ
NVUGIB ||| S:612 E:618 ||| NNP
.  ||| S:618 E:620 ||| .
A  ||| S:620 E:622 ||| DT
retrospective  ||| S:622 E:636 ||| JJ
cohort  ||| S:636 E:643 ||| JJ
study  ||| S:643 E:649 ||| NN
examined  ||| S:649 E:658 ||| VBD
further  ||| S:658 E:666 ||| JJ
bleeding  ||| S:666 E:675 ||| NN
and  ||| S:675 E:679 ||| CC
30-day  ||| S:679 E:686 ||| JJ
and  ||| S:686 E:690 ||| CC
1-year  ||| S:690 E:697 ||| CD
mortality  ||| S:697 E:707 ||| NN
in  ||| S:707 E:710 ||| IN
adult  ||| S:710 E:716 ||| NN
patients  ||| S:716 E:725 ||| NNS
who  ||| S:725 E:729 ||| WP
underwent  ||| S:729 E:739 ||| VBD
gastroscopy  ||| S:739 E:751 ||| VBN
for  ||| S:751 E:755 ||| IN
suspected  ||| S:755 E:765 ||| JJ
acute  ||| S:765 E:771 ||| JJ
NVUGIB  ||| S:771 E:778 ||| NN
between  ||| S:778 E:786 ||| IN
2008  ||| S:786 E:791 ||| CD
and  ||| S:791 E:795 ||| CC
2010  ||| S:795 E:800 ||| CD
in  ||| S:800 E:803 ||| IN
three  ||| S:803 E:809 ||| CD
tertiary  ||| S:809 E:818 ||| CD
hospitals  ||| S:818 E:828 ||| NNS
in  ||| S:828 E:831 ||| IN
Western  ||| S:831 E:839 ||| NNP
Australia ||| S:839 E:848 ||| NNP
.  ||| S:848 E:850 ||| .
Survival  ||| S:850 E:859 ||| NN
analysis  ||| S:859 E:868 ||| NN
was  ||| S:868 E:872 ||| VBD
performed ||| S:872 E:881 ||| VBN
.  ||| S:881 E:883 ||| .
A  ||| S:883 E:885 ||| DT
total  ||| S:885 E:891 ||| NN
of  ||| S:891 E:894 ||| IN
2228  ||| S:894 E:899 ||| CD
adults  ||| S:899 E:906 ||| NNS
( ||| S:906 E:907 ||| -LRB-
63 ||| S:907 E:909 ||| CD
%  ||| S:909 E:911 ||| NN
male ||| S:911 E:915 ||| NN
)  ||| S:915 E:917 ||| -RRB-
with  ||| S:917 E:922 ||| IN
2360  ||| S:922 E:927 ||| CD
hospital  ||| S:927 E:936 ||| NN
admissions  ||| S:936 E:947 ||| NNS
for  ||| S:947 E:951 ||| IN
NVUGIB  ||| S:951 E:958 ||| NNP
met  ||| S:958 E:962 ||| VBD
the  ||| S:962 E:966 ||| DT
inclusion  ||| S:966 E:976 ||| NN
criteria ||| S:976 E:984 ||| NNS
.  ||| S:984 E:986 ||| .
Median  ||| S:986 E:993 ||| JJ
age  ||| S:993 E:997 ||| NN
at  ||| S:997 E:1000 ||| IN
presentation  ||| S:1000 E:1013 ||| NN
was  ||| S:1013 E:1017 ||| VBD
70  ||| S:1017 E:1020 ||| CD
years  ||| S:1020 E:1026 ||| NNS
( ||| S:1026 E:1027 ||| -LRB-
range ||| S:1027 E:1032 ||| NN
,  ||| S:1032 E:1034 ||| ,
19-99  ||| S:1034 E:1040 ||| CD
years ||| S:1040 E:1045 ||| NNS
) ||| S:1045 E:1046 ||| -RRB-
.  ||| S:1046 E:1048 ||| .
Thirty-day  ||| S:1048 E:1059 ||| JJ
mortality  ||| S:1059 E:1069 ||| NN
was  ||| S:1069 E:1073 ||| VBD
4.9 ||| S:1073 E:1076 ||| CD
%  ||| S:1076 E:1078 ||| NN
and  ||| S:1078 E:1082 ||| CC
1-year  ||| S:1082 E:1089 ||| CD
mortality  ||| S:1089 E:1099 ||| NN
was  ||| S:1099 E:1103 ||| VBD
13.9 ||| S:1103 E:1107 ||| CD
% ||| S:1107 E:1108 ||| NN
.  ||| S:1108 E:1110 ||| .
Transfusion  ||| S:1110 E:1122 ||| NN
of  ||| S:1122 E:1125 ||| IN
4  ||| S:1125 E:1127 ||| CD
or  ||| S:1127 E:1130 ||| CC
more  ||| S:1130 E:1135 ||| JJR
units  ||| S:1135 E:1141 ||| NNS
of  ||| S:1141 E:1144 ||| IN
RBCs  ||| S:1144 E:1149 ||| NNP
was  ||| S:1149 E:1153 ||| VBD
associated  ||| S:1153 E:1164 ||| VBN
with  ||| S:1164 E:1169 ||| IN
greater  ||| S:1169 E:1177 ||| JJR
than  ||| S:1177 E:1182 ||| IN
10  ||| S:1182 E:1185 ||| CD
times  ||| S:1185 E:1191 ||| NNS
the  ||| S:1191 E:1195 ||| DT
odds  ||| S:1195 E:1200 ||| NNS
of  ||| S:1200 E:1203 ||| IN
further  ||| S:1203 E:1211 ||| JJ
bleeding  ||| S:1211 E:1220 ||| NN
in  ||| S:1220 E:1223 ||| IN
patients  ||| S:1223 E:1232 ||| NNS
with  ||| S:1232 E:1237 ||| IN
a  ||| S:1237 E:1239 ||| DT
hemoglobin  ||| S:1239 E:1250 ||| NN
level  ||| S:1250 E:1256 ||| NN
of  ||| S:1256 E:1259 ||| IN
more  ||| S:1259 E:1264 ||| JJR
than  ||| S:1264 E:1269 ||| IN
90  ||| S:1269 E:1272 ||| CD
g ||| S:1272 E:1273 ||| CD
/ ||| S:1273 E:1274 ||| CD
L  ||| S:1274 E:1276 ||| NNP
( ||| S:1276 E:1277 ||| -LRB-
odds  ||| S:1277 E:1282 ||| JJ
ratio ||| S:1282 E:1287 ||| NN
,  ||| S:1287 E:1289 ||| ,
11.9 ||| S:1289 E:1293 ||| CD
;  ||| S:1293 E:1295 ||| :
95 ||| S:1295 E:1297 ||| CD
%  ||| S:1297 E:1299 ||| NN
confidence  ||| S:1299 E:1310 ||| NN
interval  ||| S:1310 E:1319 ||| NNS
[ ||| S:1319 E:1320 ||| -LRB-
CI ||| S:1320 E:1322 ||| NNP
] ||| S:1322 E:1323 ||| -RRB-
,  ||| S:1323 E:1325 ||| ,
3.1-45.7 ||| S:1325 E:1333 ||| NNP
;  ||| S:1333 E:1335 ||| :
p  ||| S:1335 E:1337 ||| CD
≤  ||| S:1337 E:1339 ||| CD
0.001 ||| S:1339 E:1344 ||| CD
) ||| S:1344 E:1345 ||| -RRB-
,  ||| S:1345 E:1347 ||| ,
but  ||| S:1347 E:1351 ||| CC
was  ||| S:1351 E:1355 ||| VBD
not  ||| S:1355 E:1359 ||| RB
associated  ||| S:1359 E:1370 ||| VBN
with  ||| S:1370 E:1375 ||| IN
mortality ||| S:1375 E:1384 ||| NN
.  ||| S:1384 E:1386 ||| .
Administration  ||| S:1386 E:1401 ||| NN
of  ||| S:1401 E:1404 ||| IN
5  ||| S:1404 E:1406 ||| CD
or  ||| S:1406 E:1409 ||| CC
more  ||| S:1409 E:1414 ||| JJR
units  ||| S:1414 E:1420 ||| NNS
of  ||| S:1420 E:1423 ||| IN
fresh-frozen  ||| S:1423 E:1436 ||| JJ
plasma  ||| S:1436 E:1443 ||| NNS
( ||| S:1443 E:1444 ||| -LRB-
FFP ||| S:1444 E:1447 ||| NNP
)  ||| S:1447 E:1449 ||| -RRB-
was  ||| S:1449 E:1453 ||| VBD
associated  ||| S:1453 E:1464 ||| VBN
with  ||| S:1464 E:1469 ||| IN
increased  ||| S:1469 E:1479 ||| JJ
30-day  ||| S:1479 E:1486 ||| JJ
( ||| S:1486 E:1487 ||| -LRB-
hazard  ||| S:1487 E:1494 ||| NN
ratio ||| S:1494 E:1499 ||| NN
,  ||| S:1499 E:1501 ||| ,
2.8 ||| S:1501 E:1504 ||| CD
;  ||| S:1504 E:1506 ||| :
95 ||| S:1506 E:1508 ||| CD
%  ||| S:1508 E:1510 ||| NN
CI ||| S:1510 E:1512 ||| NNP
,  ||| S:1512 E:1514 ||| ,
1.3-5.9 ||| S:1514 E:1521 ||| NNP
;  ||| S:1521 E:1523 ||| :
p  ||| S:1523 E:1525 ||| CD
=  ||| S:1525 E:1527 ||| CD
0.008 ||| S:1527 E:1532 ||| CD
)  ||| S:1532 E:1534 ||| -RRB-
and  ||| S:1534 E:1538 ||| CC
1-year  ||| S:1538 E:1545 ||| NNP
( ||| S:1545 E:1546 ||| -LRB-
hazard  ||| S:1546 E:1553 ||| NN
ratio ||| S:1553 E:1558 ||| NN
,  ||| S:1558 E:1560 ||| ,
2.6 ||| S:1560 E:1563 ||| CD
;  ||| S:1563 E:1565 ||| :
95 ||| S:1565 E:1567 ||| CD
%  ||| S:1567 E:1569 ||| NN
CI ||| S:1569 E:1571 ||| NNP
,  ||| S:1571 E:1573 ||| ,
1.3-5.0 ||| S:1573 E:1580 ||| NNP
;  ||| S:1580 E:1582 ||| :
p  ||| S:1582 E:1584 ||| CD
=  ||| S:1584 E:1586 ||| CD
0.005 ||| S:1586 E:1591 ||| CD
)  ||| S:1591 E:1593 ||| -RRB-
mortality  ||| S:1593 E:1603 ||| NN
after  ||| S:1603 E:1609 ||| IN
adjusting  ||| S:1609 E:1619 ||| VBG
for  ||| S:1619 E:1623 ||| IN
coagulopathy ||| S:1623 E:1635 ||| NN
,  ||| S:1635 E:1637 ||| ,
comorbidity ||| S:1637 E:1648 ||| NN
,  ||| S:1648 E:1650 ||| ,
Rockall  ||| S:1650 E:1658 ||| NNP
score ||| S:1658 E:1663 ||| NN
,  ||| S:1663 E:1665 ||| ,
and  ||| S:1665 E:1669 ||| CC
other  ||| S:1669 E:1675 ||| JJ
covariates ||| S:1675 E:1685 ||| NN
.  ||| S:1685 E:1687 ||| .
In  ||| S:1687 E:1690 ||| IN
this  ||| S:1690 E:1695 ||| DT
large ||| S:1695 E:1700 ||| JJ
,  ||| S:1700 E:1702 ||| ,
multicenter  ||| S:1702 E:1714 ||| JJ
study  ||| S:1714 E:1720 ||| NN
of  ||| S:1720 E:1723 ||| IN
NVUGIB ||| S:1723 E:1729 ||| NNP
,  ||| S:1729 E:1731 ||| ,
RBC  ||| S:1731 E:1735 ||| NNP
transfusion  ||| S:1735 E:1747 ||| NN
was  ||| S:1747 E:1751 ||| VBD
associated  ||| S:1751 E:1762 ||| VBN
with  ||| S:1762 E:1767 ||| IN
further  ||| S:1767 E:1775 ||| JJ
bleeding  ||| S:1775 E:1784 ||| NN
but  ||| S:1784 E:1788 ||| CC
not  ||| S:1788 E:1792 ||| RB
mortality ||| S:1792 E:1801 ||| NN
,  ||| S:1801 E:1803 ||| ,
while  ||| S:1803 E:1809 ||| IN
FFP  ||| S:1809 E:1813 ||| NNP
transfusion  ||| S:1813 E:1825 ||| NN
was  ||| S:1825 E:1829 ||| VBD
associated  ||| S:1829 E:1840 ||| VBN
with  ||| S:1840 E:1845 ||| IN
increased  ||| S:1845 E:1855 ||| JJ
mortality  ||| S:1855 E:1865 ||| NN
in  ||| S:1865 E:1868 ||| IN
a  ||| S:1868 E:1870 ||| DT
subset  ||| S:1870 E:1877 ||| NN
of  ||| S:1877 E:1880 ||| IN
patients ||| S:1880 E:1888 ||| NNS
.  ||| S:1888 E:1890 ||| .
